JAK1 and non-small cell lung carcinoma: Wan et al., 2021 reported that miRNA-140-3p represses the proliferation of lung adenocarcinoma cells by targeting thymidylate synthetase 70; Hu et al., 2022 also reported that miR-140-3p inhibits the progression of NSCLC by targeting Janus kinase 1 71.